EXCLUSIVE: SpaceX IPO Could Ignite These 5 Space Stocks — One Even Holds Private Shares Of Musk's Company

Procure Holdings CEO Andrew Chanin says space stocks are gaining momentum into 2026 amid a Trump executive order and the prospect of a SpaceX IPO, driving investor interest in pure-play exposure via the Procure Space ETF (NASDAQ:UFO). Key UFO positions include Rocket Lab (5.4%), EchoStar (4.8%) — which holds SpaceX private equity acquired at a valuation below cited $800B–$1.5T IPO ranges — and AST SpaceMobile (4.3%); Chanin suggests a SpaceX IPO could reprice related names and lift visibility for recent space IPOs such as Firefly (FLY) and Voyager (VOYG).

Analysis

Winners are spectrum holders (EchoStar/SATS), vertically integrated launch-to-sat players (SpaceX comps, RKLB) and niche connectivity plays (ASTS) as a SpaceX IPO converts private implied value into public comparables; losers include pure-play low-margin launchers and any firms with spectrum/legal overhangs. Expect a re-rating wave (PE/EV expansion of 20–50% for direct comparables within 6–12 months of an S‑1), but also margin squeeze for commodity launch services if entrants scale capacity faster than demand over 12–36 months.

Principal tail risks: a failed/withdrawn IPO, regulatory restrictions on spectrum/foreign ownership, or a high-profile launch failure that triggers investor flight to safety; these could knock 30–70% off speculative names in days. Hidden dependencies include lockup expiries (EchoStar’s SpaceX stake liquidity), downstream operator contracts, and government procurement cycles — monitor tradeable lockup and contract milestone dates within 30–90 days.

Trade implications: favor selective longs in SATS (EchoStar), RKLB (Rocket Lab) and ASTS with tight sizing: 2–4% NAV each as thematic core positions ahead of 2026 IPO signaling; use 6–12 month horizons and trim into rallies of +30–50%. Implement option structures to control drawdowns: buy 9–12 month call spreads on SATS/RKLB at 30–50% OTM and sell short-dated covered calls on UFO to monetize near-term IV spikes around IPO rumors.

Contrarian view: the market is extrapolating SpaceX private value — the consensus may be overvaluing embedded stakes; if SpaceX pricing targets fall < $800B on filing, expect a fast 25–40% mean reversion in mispriced moonshot names. Historical analog: post-IPO comp re-rating in semiconductors (2000s) shows public liquidity often consolidates winners and bankruptcies among small-cap suppliers within 24 months, so size and liquidity screening matter more than theme exposure.

Key Decisions for Investors

• Establish a 2–4% NAV long position in SATS (EchoStar) within 30 days, target +40% upside on a re-rate into a $800B+ implied SpaceX valuation; set a hard stop at -20% and trim half of position at +30%.
• Add a 2–3% NAV long in RKLB (Rocket Lab) as a diversified launch/manufacturing play; hedge with buy 9–12 month RKLB 30–50% OTM call spreads (finance with selling near-term calls) and take profits if RKLB rallies >50% or following an S‑1 filing from SpaceX.
• Initiate a 1–2% NAV speculative long in ASTS with conviction-sizing limited to 1–2% due to execution risk; buy 6–9 month ATM or 10–20% ITM protective puts (cost limit <4% of position) to cap downside from regulatory or technical setbacks.
• Short-size (1–2% NAV) high-beta space/tech small-caps ETF exposure via short UFO or buy put spreads if IPO hype exceeds fundamentals (monitor S‑1 rumors and volume spikes); target mean reversion of 20–40% within 3–9 months and cover on sustained underperformance relative to SATS/RKLB.
• Monitor three binary catalysts before scaling positions: (1) SpaceX S‑1 filing or credible timeline within 90–180 days, (2) EchoStar lockup/liquidity events and contract milestone disclosures within 30–120 days, and (3) any major launch failure or executive order implementation — add only after catalyst confirmation or take profits if catalysts are delayed >180 days.